109047 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof General methods applicable to biologically active non-coding nucleic acids
Inducible, tunable, and multiplex human gene regulation using CRISPR-Cpf1
#1502CHIMERIC ANTIGEN RECEPTOR T CELLS DERIVED FROM IMMUNOENGINEERED PLURIPOTENT STEM CELLS
#1503METHODS FOR COMBINATORIAL SCREENING AND USE OF THERAPEUTIC TARGETS THEREOF
#1504Compositions of Asymmetric Interfering RNA and Uses Thereof
#1505NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS
#1506Treatment Of Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, And Liver Fibrosis
#1507Nuclease-mediated nucleic acid modification
#1508CRISPR-Cas effector polypeptides and methods of use thereof
#1509RECOMBINANT CRISPR-CAS9 NUCLEASES WITH ALTERED PAM SPECIFICITY
#1510Compositions and methods for transient gene therapy with enhanced stability
#1511System and Methods for Engineering Bacteria Fit for Eukaryotic mRNA Production, Export, and Translation in a Eukaryotic Host
#1512Extended dicer substrate agents and methods for the specific inhibition of gene expression
#1513NATURAL GUIDE ARCHITECTURES AND METHODS OF MAKING AND USING THE SAME
#1514AMINE CATIONIC LIPIDS AND USES THEREOF
#1515TARGETED ELIMINATION OF BACTERIAL GENES
#1516METHODS AND COMPOSITIONS FOR GENETICALLY MANIPULATING GENES AND CELLS
#1517ANTISENSE NUCLEIC ACIDS
#1518CIRCULARIZED ENGINEERED RNA AND METHODS
#1519CHEMICALLY-MODIFIED GUIDE RNAS TO IMPROVE CRISPR-CAS PROTEIN SPECIFICITY
#1520Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
#1521A RODENT MODEL OF B4GALT1-MEDIATED FUNCTIONS
#1522SYNTHETIC GUIDE MOLECULES, COMPOSITIONS AND METHODS RELATING THERETO
#1523MODIFICATION OF SMALL RNAS FOR THERAPEUTIC USES
#1524CRISPR-associated (Cas) protein
#1525Sideroflexins as mitochondrial serine transporters
#1526DELIVERY OF RNA TO DIFFERENT CELL TYPES
#1527Lipid formulations for nucleic acid delivery
#1528RAAV-MEDIATED NUCLEASE-ASSOCIATED VECTOR INTEGRATION (RAAV-NAVI)
#1529Compositions and methods of inhibiting gene expression in a lung
#1530Packaging oligonucleotides into virus-like particles
#1531Compositions and methods for organ specific delivery of nucleic acids
#1532Methods of genetic mediated engineering of RNAi models
#1533CRISPR enabled multiplexed genome engineering
#1534Oligonucleotide comprising an inosine for treating DMD
#1535iRNA AGENTS WITH BIOCLEAVABLE TETHERS
#1536Structurally designed shRNAs
#1537Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
#1538METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION
#1539RAAV-based compositions and methods for treating amyotrophic lateral sclerosis
#1540ENGINEERED BI-STABLE TOGGLE SWITCH AND USES THEREOF
#1541METHODS AND COMPOSITIONS FOR HOMOLOGY DIRECTED REPAIR OF DOUBLE STRAND BREAKS IN PLANT CELL GENOMES
#1542Oligonucleotide Conjugates
#1543Selective antisense compounds and uses thereof
#1544MRNA display antibody library and methods
#1545CRISPR-Cas effector polypeptides and methods of use thereof
#1546Enhanced placental stem cells and uses thereof
#1547Engineering Extracellular Vesicles for Affinity Purification
#1548Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#1549INDUCIBLE MODIFICATION OF A CELL GENOME
#1550METHODS AND COMPOSITIONS FOR ENHANCING FUNCTIONAL MYELIN PRODUCTION
#1551Micro-RNAS and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
#1552BIODEGRADABLE AND CLINICALLY-COMPATIBLE NANOPARTICLES AS DRUG DELIVERY CARRIERS
#1553Targeted Self-Assembly of Functionalized Carbon Nanotubes on Tumors
#1554PRECISE DELETION OF CHROMOSOMAL SEQUENCES IN VIVO AND TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS USING ENGINEERED NUCLEASES
#1555Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#1556MODIFIED AAV CONSTRUCTS AND USES THEREOF
#1557ANTISENSE NUCLEIC ACIDS
#1558Chemically Ligated RNAs for CRISPR/Cas9-lgRNA Complexes as Antiviral Therapeutic Agents
#1559CRISPR-CAS SYSTEMS HAVING DESTABILIZATION DOMAIN
#1560PEPTIDE/PARTICLE DELIVERY SYSTEMS
#1561NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY
#1562DIRECTED EVOLUTION
#1563Nucleic Acid Carriers And Therapeutic Methods of Use
#1564POLYVINYL ALCOHOL-DEGRADING ENZYME AND PROCESS FOR PRODUCING THE SAME
#1565STAT3 INHIBITORS AND USES THEREOF
#1566Methods and compositions for inhibiting detoxification response
#1567RNA-INTERFERENCE-INDUCING NUCLEIC ACID MOLECULE ABLE TO PENETRATE INTO CELLS, AND USE THEREFOR
#1568METHODS AND COMPOSITIONS FOR THE MAKING AND USING OF GUIDE NUCLEIC ACIDS
#1569Isolation of novel AAV's and uses thereof
#1570METHODS FOR DETERMINING THE PRESENCE OR RISK OF DEVELOPING FACIOSCAPULOHUMERAL DYSTROPHY (FSHD)
#1571Methods for extending polynucleotides
#1572Antisense nucleic acids
#1573Nucleic acid-guided nucleases
#1574Exon skipping compositions for treating muscular dystrophy
#1575MULTIPLE EXON SKIPPING COMPOSITIONS FOR DMD
#1576ANTISENSE NUCLEIC ACIDS
#1577Oligonucleotides comprising modified nucleosides
#1578Agents useful in treating facioscapulohumeral muscular dystrophy
#1579AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
#1580RNA/DNA HYBRID NANOPARTICLES MODIFIED WITH SINGLE STRANDED RNA TOEHOLDS AND USES THEREOF
#1581NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#1582Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide
#1583Composition for inhibiting ice recrystallization
#1584Use of trinucleotide repeat RNAs to treat cancer
#1585REDUCED SIZE SELF-DELIVERING RNAI COMPOUNDS
#1586ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES
#1587Selective Antisense Compounds and Uses Thereof
#1588Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof
#1589Targeted delivery system
#1590REFERENCE APTAMER SENSING ELEMENTS FOR EAB BIOSENSORS
#1591Antisense oligonucleotides useful in treatment of Pompe disease
#1592MODIFIED GUIDE RNAS, CRISPR-RIBONUCLEOTPROTEIN COMPLEXES AND METHODS OF USE
#1593NOVEL CRISPR RNA TARGETING ENZYMES AND SYSTEMS AND USES THEREOF
#1594SYSTEMS AND METHODS FOR PLANT GENOME EDITING USING CAS 12a ORTHOLOGS
#1595COMPOSITIONS AND METHODS
#1596Chiral control
#1597Method to inactivate a mutant allele of an gene
#1598Optimized small guide RNAs and methods of use
#1599De novo designed non-local beta sheet proteins
#1600Method for creating new germplasm of male sterile crop by gene editing and application thereof
#1601Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof
#1602RNA nanoparticles for brain tumor treatment
#1603Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#1604Simultaneous gene silencing and suppressing gene silencing in ihe same cell
#1605TARGETED AUGMENTATION OF NUCLEAR GENE OUTPUT
#1606MicroRNA Compounds and Methods for Modulating MIR-122
#1607Hybrid recombinant adeno-associated virus serotype between AAV9 and AAVrh74 with reduced liver tropism
#1608Methods of delivering anionic agents in vivo using non-viral nanoparticle-based delivery systems
#1609COMPOSITIONS AND METHODS FOR NUCLEIC ACID TRANSFER
#1610Aminoalcohol lipidoids and uses thereof
#1611LOADING OF EXTRACELLULAR VESICLES THROUGH IMPARTING OF MECHANICAL SHEAR
#1612Insecticidal proteins from plants and methods for their use
#1613Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#1614METHODS AND COMPOSITIONS FOR HOMOLOGY-DIRECTED REPAIR OF CAS ENDONUCLEASE MEDIATED DOUBLE STRAND BREAKS
#1615Compositions and methods for modulating apolipoprotein (a) expression
#1616Modified promoter
#1617OLIGONUCLEOTIDES COMPRISING ACYCLIC AND ABASIC NUCLEOSIDES AND ANALOGS
#1618METHOD FOR OPENING TIGHT JUNCTIONS
#1619Branched oligonucleotides
#1620Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#1621Anti-connexin compounds targeted to connexins and methods of use thereof
#1622Antisense oligonucleotide compositions
#1623GUIDE RNA WITH CHEMICAL MODIFICATIONS
#1624CRISPR-associated (CAS) protein
#1625Vesicles comprising a PTEN inhibitor and uses of same
#1626Methods and compositions for RNA-guided treatment of HIV infection
#1627MIRNA MODULATION OF T CELL SIGNALING AND USES THEREOF
#1628Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#1629Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#1630Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#1631Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#1632Interfering RNA molecules
#1633Extended dicer substrate agents and methods for the specific inhibition of gene expression
#1634COMPLEX OF POLYSACCHARIDE AND DOUBLE-STRANDED RNA AND METHOD OF INHIBITING EXPRESSION OF A TARGET GENE IN A CELL
#1635DEFIBROTIDE FOR USE IN PROPHYLAXIS AND/OR TREATMENT OF GRAFT VERSUS HOST DISEASE (GVHD)
#1636Liposomal particles, methods of making same and uses thereof
#1637COMPOSITION FOR CLEAVING A TARGET DNA COMPRISING A GUIDE RNA SPECIFIC FOR THE TARGET DNA AND CAS PROTEIN-ENCODING NUCLEIC ACID OR CAS PROTEIN, AND USE THEREOF
#1638COMPOSITION FOR CLEAVING A TARGET DNA COMPRISING A GUIDE RNA SPECIFIC FOR THE TARGET DNA AND CAS PROTEIN-ENCODING NUCLEIC ACID OR CAS PROTEIN, AND USE THEREOF
#1639Modified oligonucleotides and methods of use
#1640Antisense molecules and methods for treating pathologies
#1641Genetic correction of mutated genes
#1642Artificial Target Cells for in-vitro CAR Cytotoxicity and ADCC validation
#1643Modulators of IRF4 expression
#1644Lipid-derived neutral nanoparticles
#1645Transgenic microalgae and use thereof as a feed for delivery of interfering RNA molecules
#1646Read through of truncated proteins in premature termination codon diseases using an optimized genetic codon expansion system
#1647Fully stabilized asymmetric siRNA
#1648COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION
#1649Methods And Compositions For Templated Assembly Of Nucleic Acid Specific Heterocompounds
#1650PKC PATHWAY IN PARKINSON'S DISEASE
#1651Modified double-stranded RNA agents
#1652Synthetic nucleic acids having non-natural structures
#1653Combination comprising immunostimulatory oligonucleotides
#1654Direct oligonucleotide synthesis on cells and biomolecules
#1655METHODS AND COMPOSITIONS FOR IMPROVING PLANT TRAITS
#1656Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
#1657BACTERIAL IDENTIFICATION METHOD USING RNA OF SAMPLE BACTERIA, AND KIT THEREFOR
#1658Methods and compositions for modulating apolipoprotein (a) expression
#1659Method of synthesis of an ionizable cationic lipid
#1660METHODS OF MODULATING ANTISENSE ACTIVITY
#1661Method for generating a genetically modified pig with inactivated porcine endogenous retrovirus (PERV) elements
#1662Nourin gene-based RNA molecular network: novel early diagnostic and prognostic biomarkers for coronary artery disease, unstable angina, STEMI/NSTEMI and heart failure
#1663Engineered CRISPR-Cas9 nucleases with altered PAM specificity
#1664Engineered CRISPR-Cas9 nucleases with altered PAM specificity
#1665NOVEL RNAi MOLECULE DELIVERY PLATFORM BASED ON SINGLE-siRNA AND shRNA NANOCAPSULES
#1666Method for diagnosis of Alzheimer's disease using microRNA
#1667CRISPR enabled multiplexed genome engineering
#1668ITERATIVE GENOME ASSEMBLY
#1669Short interfering nucleic acid (siNA) compositions
#1670Oligomeric compounds comprising bicyclic nucleotides and uses thereof
#1671Method for screening splicing variants or events
#1672DELIVERING CRISPR THERAPEUTICS WITH LIPID NANOPARTICLES
#1673Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase
#1674CTLA-4 aptamer conjugates
#1675Modulating dsRNA editing, sensing, and metabolism to increase tumor immunity and improve the efficacy of cancer immunotherapy and/or modulators of intratumoral interferon
#1676Methods for modifying RNA splicing
#1677Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
#1678Integrin ligands and uses thereof
#1679Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#1680Protected guide RNAS (pgRNAS)
#1681METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT
#1682Method of target cleaving using CRISPR hybrid DNA/RNA polynucleotides
#1683Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#1684Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#1685Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#1686Methods for genomic integration
#1687Polynucleotides, compositions, and methods for genome editing
#1688Method to Implement a CRISPR Gene Drive in Mammals
#1689Oligonucleotides for inducing paternal UBE3A expression
#1690Compositions and methods for rapid and dynamic flux control using synthetic metabolic valves
#1691Liposomes for modulating Wiskott-Aldrich syndrome protein
#1692RECOMBINANT INSECT VECTORS AND METHODS OF USE
#1693COMPLEMENT COMPONENT iRNA COMPOSITIONS AND METHODS OF USE THEREOF
#1694RNAi CONJUGATES, PARTICLES AND FORMULATIONS THEREOF
#1695NUCLEIC ACID NANOSTRUCTURES WITH CORE MOTIFS
#1696RAAV-based compositions and methods
#1697Multivalent oligonucleotide assemblies
#1698Bioactive conjugates for oligonucleotide delivery
#1699OLIGONUCLEOTIDES COMPRISING A PHOSPHORODITHIOATE INTERNUCLEOSIDE LINKAGE
#1700High Specificity Genome Editing Using Chemically Modified Guide RNAs
#1701Compositions and methods for making selenocysteine containing polypeptides
#1702ANTISENSE OLIGONUCLEOTIDE DIRECTED REMOVAL OF PROTEOLYTIC CLEAVAGE SITES FROM PROTEINS
#1703DIFFERENTIAL KNOCKOUT OF AN ALLELE OF A HETEROZYGOUS FIBRINOGEN ALPHA CHAIN (FGA) GENE
#1704METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#1705LNA-G process
#1706Cell-penetrating peptides for antisense delivery
#1707METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#1708METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#1709METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#1710CRISPR-related methods and compositions with governing gRNAS
#1711Composition for delivery of genetic material
#1712RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
#1713Expression cassette
#1714Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#1715Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#1716Expression cassette for production of high-expression and high-functionality target protein and use thereof
#1717Methods for genetic modification of plants
#1718RNA INTERFERENCE MEDIATING SMALL RNA MOLECULES
#1719Compositions and methods for rapid and dynamic flux control using synthetic metabolic valves
#1720Method for reducing an immune response by administering an immune evading adeno-associated AAV8 or AAVDJ viral vector
#1721Therapy specific, pre-programmed auto injection device
#1722ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES
#1723Oligonucleotide comprising an inosine for treating DMD
#1724METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF RNA SILENCING
#1725DETERMINISTIC MECHANOPORATION FOR CELL ENGINEERING
#1726Preeclampsia
#1727Delivery method of target material into extracellular vesicles using extracorporeal shockwave
#1728Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
#1729ALBUMIN PRODUCTION AND CELL PROLIFERATION
#1730Compositions and Methods for Inhibiting Expression of Transthyretin
#1731Reducing nonsense-mediated MRNA decay
#1732BIOTIN COMPLEXES FOR TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE
#1733NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOF
#1734Methods and compositions for gene editing in hematopoietic stem cells
#1735METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#1736SYNTHETIC HAMMERHEAD RIBOZYMES WITH LIGAND-RESPONSIVE TERTIARY INTERACTIONS
#17372'-METHOXY SUBSTITUTED OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN GENE MODULATIONS
#1738ANTISENSE COMPOUNDS
#1739Methods and compositions for selecting siRNA of improved functionality
#1740RNA SEQUENCE-SPECIFIC MEDIATORS OF RNA INTERFERENCE
#1741Compositions and methods for the expression of CRISPR guide RNAs using the H1 promoter
#1742RNA-modulating agents
#1743ALTERED GUIDE RNAS FOR MODULATING CAS9 ACTIVITY AND METHODS OF USE
#1744Complement component iRNA compositions and methods of use thereof
#1745Gene knockout method
#1746Therapeutic compositions
#1747Enhanced selection of efficient targeted genome manipulating agents
#1748MULTI-CONJUGATE OF SIRNA AND PREPARING METHOD THEREOF
#1749Compositions and methods for regulating proteins and nucleic acids activities
#1750Tracking and manipulating cellular RNA via nuclear delivery of CRISPR/CAS9
#1751Dynamic control of colocalization of proteins
#1752Cancer treatment
#1753BICYCLIC PEPTIDE OLIGONUCLEOTIDE CONJUGATES
#1754NUCLEIC ACID-GUIDED NUCLEASES
#1755Reducing intron retention
#1756Agents useful in treating facioscapulohumeral muscular dystrophy
#1757Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
#1758SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS
#1759ENCAPSULATED POLYNUCLEOTIDES AND METHODS OF USE
#1760ANTISENSE OLIGONUCLEOTIDE DIRECTED REMOVAL OF PROTEOLYTIC CLEAVAGE SITES, THE HCHWA-D MUTATION, AND TRINUCLEOTIDE REPEAT EXPANSIONS
#1761COMPOSITIONS AND METHODS FOR MODULATING HBV EXPRESSION
#1762Biodegradable lipids for delivery of nucleic acids
#1763CONDITIONAL PROTEIN TRANSLATION SWITCHES, CONDITIONAL GENE EXPRESSION SYSTEMS AND USES THEREOF
#1764Continuous evolution for stabilized proteins
#1765Oligonucleotide analogues incorporating 5-aza-cytosine therein
#1766Microbubble nucleic acid delivery platform
#1767Engineered nucleic acid-targeting nucleic acids
#1768CHIMERIC RECEPTORS
#1769Methods of treating mitochondrial disorders
#1770Methods and compositions for screening and treating developmental disorders
#1771ANALYSIS SYSTEM FOR PERIPHERAL BLOOD-BASED NON-INVASIVE DETECTION OF LESION IMMUNE REPERTOIRE DIVERSITY AND USES OF SYSTEM
#1772Modulatory polynucleotides
#1773Allele-specific therapy for Huntington disease haplotypes
#1774POROUS NANOPARTICLE-SUPPORTED LIPID BILAYER DELIVERY OF TRANSCRIPTIONAL GENE MODULATORS
#1775DNA methylation editing kit and DNA methylation editing method
#1776Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#1777Method of Off-Target Recording of Spacer Sequences within a Cell In Vivo
#1778Peptide, complex of peptide and siRNA, and methods of use thereof
#1779HYBRID FORMULATION OF RESPONSIVE POLYMERIC NANOCARRIERS FOR THERAPEUTIC AND DIAGNOSTIC DELIVERY
#1780Systems, methods, and compositions for targeted nucleic acid editing
#1781COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING
#1782NUCLEIC ACIDS COMPRISING IMPREFECT HAIRPINS
#1783Covalently fused viral coat proteins for the display of target molecules
#1784Use of a combination of Dbait molecule and PARP inhibitors to treat cancer
#1785PROBE AND METHOD FOR DETECTING TRANSCRIPT RESULTING FROM FUSION GENE AND/OR EXON SKIPPING
#1786COMPOSITION AND METHOD OF USING MIR-302 PRECURSORS AS ANTI-CANCER DRUGS FOR TREATING HUMAN LUNG CANCER
#1787Compositions and methods related to a type-II CRISPR-Cas system in
#1788CRISPR enabled multiplexed genome engineering
#1789CRISPR enabled multiplexed genome engineering
#1790Compositions and methods for gene editing
#1791Systems and methods for the treatment of hemoglobinopathies
#1792Modulation of Wnt5a to Treat Glaucoma
#1793CRISPR/RNA-guided nuclease systems and methods
#1794Modulatory polynucleotides
#1795Antisense nucleic acids
#1796Engineered CRISPR-Cas9 nucleases with altered PAM specificity
#1797Special fire protection system for runaway grass and forest fires and method for use
#1798COMPOSITIONS AND METHODS FOR ENHANCING THE THERAPEUTIC POTENTIAL OF STEM CELLS
#1799Micellic assemblies
#1800Oligonucleotide analogues targeting human LMNA